Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
This study has been terminated.
Sponsor:
Akros Pharma Inc.
Information provided by (Responsible Party):
Akros Pharma Inc.
ClinicalTrials.gov Identifier:
NCT00997152
First received: October 14, 2009
Last updated: January 31, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 31, 2013 |